{"organizations": [], "uuid": "afc2ec522b7eef627084edeb863efe36a336dc7a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180125.html", "section_title": "Archive News &amp; Video for Thursday, 25 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-baolingbao-biologys-unit-signs-agr/brief-baolingbao-biologys-unit-signs-agreement-to-acquire-11-4-pct-stake-in-china-regenerative-medicine-idUSH9N1PE023", "country": "US", "domain_rank": 408, "title": "BRIEF-Baolingbao Biology's Unit Signs Agreement To Acquire 11.4 Pct Stake In China Regenerative Medicine", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.998, "site_type": "news", "published": "2018-01-25T16:30:00.000+02:00", "replies_count": 0, "uuid": "afc2ec522b7eef627084edeb863efe36a336dc7a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-baolingbao-biologys-unit-signs-agr/brief-baolingbao-biologys-unit-signs-agreement-to-acquire-11-4-pct-stake-in-china-regenerative-medicine-idUSH9N1PE023", "ord_in_thread": 0, "title": "BRIEF-Baolingbao Biology's Unit Signs Agreement To Acquire 11.4 Pct Stake In China Regenerative Medicine", "locations": [], "entities": {"persons": [], "locations": [{"name": "china", "sentiment": "none"}, {"name": "hong kong", "sentiment": "none"}, {"name": "china", "sentiment": "none"}], "organizations": [{"name": "baolingbao biology co ltd", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-baolingbao biology", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 25 (Reuters) - Baolingbao Biology Co Ltd:\n* SAYS UNIT SIGNS AGREEMENT TO BUY 2.0 BILLION SHARES IN CHINA REGENERATIVE MEDICINE INTERNATIONAL, OR 11.4 PERCENT STAKE, FOR HK$360 MILLION ($46.05 million) Source text in Chinese: bit.ly/2Dze5gs Further company coverage: ($1 = 7.8170 Hong Kong dollars) (Reporting by Hong Kong newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2Dze5gs"], "published": "2018-01-25T16:30:00.000+02:00", "crawled": "2018-01-26T21:13:33.004+02:00", "highlightTitle": ""}